Form 4: Community Health Systems CEO Tim Hingtgen Reports Stock Transactions

CEO Tim Hingtgen reports acquisition and disposal of Community Health Systems stock and derivative securities, including performance-based restricted shares and stock options.

Summary

• Tim Hingtgen, CEO of Community Health Systems, filed a Form 4 detailing changes in beneficial ownership.
• On March 1, 2025, Hingtgen acquired 200,000 shares of common stock and disposed of 33,600 performance-based restricted shares.
• The disposal of performance-based restricted shares was due to the vesting of 16.8% of the target number based on performance between 2022 and 2024, with the remaining 83.2% forfeited.
• Hingtgen also acquired 400,000 performance-based restricted shares tied to performance objectives between 2025 and 2027.
• Additionally, Hingtgen acquired 200,000 stock options with an exercise price of $3.01, expiring on February 28, 2035.
• Following these transactions, Hingtgen beneficially owns 1,388,781 shares of common stock and various derivative securities, including performance-based restricted shares and stock options with varying exercise prices and expiration dates.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the significant forfeiture of performance-based restricted shares, indicating underperformance against targets. However, the acquisition of new stock options and shares could be seen as a positive sign, albeit a small one.

Positives

• The acquisition of 200,000 shares of common stock by the CEO could be interpreted as a sign of confidence in the company's future.
• The granting of 400,000 performance-based restricted shares aligns management's interests with those of shareholders, incentivizing achievement of performance targets.

Negatives

• The forfeiture of 166,400 performance-based restricted shares indicates that the company did not fully achieve its performance objectives for the 2022-2024 period.
• The vesting of only 16.8% of the performance-based restricted shares suggests significant underperformance against the set targets.

Risks

• Failure to meet performance objectives for the 2025-2027, 2023-2025 and 2024-2026 performance periods could result in the forfeiture of a significant portion of the performance-based restricted shares.
• Fluctuations in the company's stock price could impact the value of the stock options held by the CEO.

Future Outlook

The vesting of future performance-based restricted shares is contingent upon the company's performance against pre-determined objectives related to Cumulative Same-Store Adjusted EBITDA Growth, Cumulative Same-Store Net Revenue Growth, and Total Shareholder Return (TSR) Percentile Rank between 2025 and 2027, 2023 and 2025, and 2024 and 2026.

Industry Context

Executive compensation in the healthcare industry often includes a mix of salary, stock options, and performance-based incentives to align management's interests with those of shareholders and to drive company performance. The specific metrics used for performance-based awards, such as EBITDA growth, revenue growth, and TSR, are common indicators of financial health and shareholder value creation in the healthcare sector.

Comparison to Industry Standards

• Community Health Systems' executive compensation structure, including performance-based restricted shares, is similar to that of other publicly traded hospital operators such as HCA Healthcare and Tenet Healthcare.
• These companies also use metrics like revenue growth, EBITDA, and TSR to determine vesting of performance-based equity awards.
• However, the specific targets and vesting percentages may vary based on company-specific goals and industry benchmarks.

Stakeholder Impact

• Shareholders may be concerned about the company's failure to meet performance objectives for the 2022-2024 period, as indicated by the forfeiture of performance-based restricted shares.
• Employees may be affected by the company's performance, as their compensation and job security could be tied to the achievement of performance targets.

Next Steps

• The vesting of the 400,000 performance-based restricted shares acquired on 03/01/2025 will depend on the company's performance between 01/01/2025 and 12/31/2027.
• The vesting of performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the '2023-2025 Performance Period').
• The vesting of performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2024 and 12/31/2026 (the '2024-2026 Performance Period').

Key Dates